Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated

John Puetz1

  • 1Department of Pediatrics, Division of Pediatric Hematology/Oncology, Saint Louis University School of Medicine, St. Louis, MO, United States.

Frontiers in Medicine
|November 29, 2023
PubMed